DD257087A5 - Verfahren zur Herstellung von biologisch aktivem Plasminogenaktivator - Google Patents

Verfahren zur Herstellung von biologisch aktivem Plasminogenaktivator Download PDF

Info

Publication number
DD257087A5
DD257087A5 DD30357587A DD30357587A DD257087A5 DD 257087 A5 DD257087 A5 DD 257087A5 DD 30357587 A DD30357587 A DD 30357587A DD 30357587 A DD30357587 A DD 30357587A DD 257087 A5 DD257087 A5 DD 257087A5
Authority
DD
German Democratic Republic
Prior art keywords
plasminogen activator
medium
human tissue
host cell
components
Prior art date
Application number
DD30357587A
Other languages
German (de)
English (en)
Inventor
William R Arathoon
Stuart E Builder
Anthony S Lubiniecki
Robert D Van Reis
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of DD257087A5 publication Critical patent/DD257087A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DD30357587A 1986-06-06 1987-06-05 Verfahren zur Herstellung von biologisch aktivem Plasminogenaktivator DD257087A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87164286A 1986-06-06 1986-06-06

Publications (1)

Publication Number Publication Date
DD257087A5 true DD257087A5 (de) 1988-06-01

Family

ID=25357832

Family Applications (1)

Application Number Title Priority Date Filing Date
DD30357587A DD257087A5 (de) 1986-06-06 1987-06-05 Verfahren zur Herstellung von biologisch aktivem Plasminogenaktivator

Country Status (21)

Country Link
US (1) US5053334A (no)
EP (1) EP0248675B1 (no)
JP (1) JPS6332484A (no)
KR (1) KR930002888B1 (no)
AT (1) ATE75775T1 (no)
AU (1) AU601984B2 (no)
DD (1) DD257087A5 (no)
DE (2) DE3778758D1 (no)
DK (1) DK175366B1 (no)
ES (1) ES2032444T3 (no)
FI (1) FI91886C (no)
FR (1) FR2599625B1 (no)
GB (1) GB2191493B (no)
GR (1) GR3005245T3 (no)
HU (1) HU205171B (no)
IE (1) IE60485B1 (no)
IL (1) IL82746A (no)
NO (1) NO170595C (no)
NZ (1) NZ220547A (no)
PT (1) PT84991B (no)
ZA (1) ZA874054B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL82746A (en) * 1986-06-06 1994-10-07 Genentech Inc A process for producing a biologically active tissue plasminogen activator
JP2576200B2 (ja) * 1988-03-09 1997-01-29 味の素株式会社 生理活性タンパク質の製造法
EP0338716A3 (en) * 1988-04-21 1990-04-11 Berlex Laboratories, Inc. Method and system for the production of non-degraded proteins from mammalian cells
DE3829244A1 (de) * 1988-08-29 1990-03-01 Boehringer Mannheim Gmbh Verfahren zur herstellung von einkettigem t-pa
CA2011548A1 (en) * 1989-03-07 1990-09-07 Hubertus Stockinger Process for the production of two-chain t-pa
GB2249099B (en) * 1990-09-26 1995-05-03 Squibb & Sons Inc Squalene synthetase
US5677184A (en) * 1994-04-19 1997-10-14 Takeda Chemical Industries, Ltd. CHO cells that express human LH-RH receptor
US6077940A (en) * 1997-12-24 2000-06-20 Genentech, Inc. Free solution ligand interaction molecular separation method
KR20050006147A (ko) 2002-04-08 2005-01-15 밀레늄 바이올로직스 인코포레이티드 자동화된 조직 엔지니어링 시스템
US8119368B2 (en) 2006-07-14 2012-02-21 Dsm Ip Assets B.V. Process for the culturing of cells
ES2657055T3 (es) * 2007-08-09 2018-03-01 Wyeth Llc Uso de perfusión para mejorar la producción de un cultivo de células alimentado por lotes en biorreactores
EP2525899A1 (en) * 2010-01-22 2012-11-28 Lonza Walkersville, Inc. High yield method and apparatus for volume reduction and washing of therapeutic cells using tangential flow filtration
US10934519B2 (en) * 2011-07-29 2021-03-02 Global Life Sciences Solutions Usa Llc Systems, methods and control laws for cell harvesting
US9695393B2 (en) * 2012-08-20 2017-07-04 Terumo Bct, Inc. Concentrating components of fluid circulated through a cell growth chamber
CN115216450A (zh) 2017-09-01 2022-10-21 隆萨沃克斯维尔股份有限公司 端到端细胞治疗自动化
SG11202106377XA (en) 2018-12-21 2021-07-29 Lonza Walkersville Inc Automated production of viral vectors
SG11202106384YA (en) 2018-12-21 2021-07-29 Octane Biotech Inc Carousel for modular biologic production units
SG11202106652WA (en) 2018-12-28 2021-07-29 Octane Biotech Inc Cell culture and tissue engineering systems with controlled environmental zones
KR20210125510A (ko) 2019-02-08 2021-10-18 론자 워커스빌 아이엔씨. 자동화 생물반응기에서 사용하기 위한 세포 농축 방법 및 장치
US20230000954A1 (en) 2021-07-02 2023-01-05 Combangio, Inc. Processes for making and using a cellular fibronectin composition

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3904480A (en) * 1972-10-24 1975-09-09 Lilly Co Eli Enhanced production of plasminogen activator
JPS5329985A (en) * 1976-08-27 1978-03-20 Kanegafuchi Chem Ind Co Ltd High concentration culturing of yeast
JPS5571496A (en) * 1978-11-24 1980-05-29 Asahi Chem Ind Co Ltd Preparation of living substance
US4409331A (en) * 1979-03-28 1983-10-11 Damon Corporation Preparation of substances with encapsulated cells
US4232124A (en) * 1979-04-23 1980-11-04 Mann George F Method of producing plasminogen activator
DE3015699C2 (de) * 1979-04-26 1982-07-15 Asahi Kasei Kogyo K.K., Osaka Herstellung eines Plasminogen-Aktivators
JPS5642584A (en) * 1979-09-18 1981-04-20 Asahi Chem Ind Co Ltd Cell cultivation method
US4420398A (en) * 1981-08-13 1983-12-13 American National Red Cross Filteration method for cell produced antiviral substances
IL68561A (en) * 1982-05-05 1991-01-31 Genentech Inc Preparation of polypeptide with human tissue plasminogen activator function,processes for making it,and dna and transformed cell intermediates thereof
JPS5951220A (ja) * 1982-08-02 1984-03-24 Asahi Chem Ind Co Ltd 新規なプラスミノ−ゲン・アクチベ−タ−およびその製法ならびにこれを含有する薬剤
US4537860A (en) * 1982-12-08 1985-08-27 Monsanto Company Static cell culture maintenance system
NZ206699A (en) * 1982-12-30 1989-08-29 Bio Response Inc Process for the production of serum independent cell lines
AU572108B2 (en) * 1983-01-19 1988-05-05 Genentech Inc. Human tpa production using vectors coding for dhfr protein
JPS59121172U (ja) * 1983-02-04 1984-08-15 ミネソタ・マイニング・アンド・マニユフアクチユアリング・コンパニ− ケーブル電線被覆の剥離部分のカバー装置
US4546083A (en) * 1983-04-22 1985-10-08 Stolle Research & Development Corporation Method and device for cell culture growth
PH22337A (en) * 1983-11-21 1988-08-12 Ciba Geigy Ag Synthesis of fibrinolytic agents by yeast
US4740461A (en) * 1983-12-27 1988-04-26 Genetics Institute, Inc. Vectors and methods for transformation of eucaryotic cells
US4888115A (en) * 1983-12-29 1989-12-19 Cuno, Incorporated Cross-flow filtration
US4757005A (en) * 1984-04-19 1988-07-12 Miles Inc. Method and cell line for obtaining plasminogen activators
WO1986005514A1 (en) * 1985-03-22 1986-09-25 Chiron Corporation EXPRESSION OF tPA IN MAMMALIAN CELLS
AU593264B2 (en) * 1985-07-10 1990-02-08 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Chromosomal DNA sequence, expression vector for human tissue plasminogen activating factor, cultured cells transfected with same and method of producing said activating factor
AU606582B2 (en) * 1985-09-06 1991-02-14 Codon Methods for the recovery of tissue plasminogen activator
JPH07110232B2 (ja) * 1985-10-14 1995-11-29 株式会社日立製作所 遺伝子組換え大腸菌の遺伝子生産物を採取する方法および装置
IL82746A (en) * 1986-06-06 1994-10-07 Genentech Inc A process for producing a biologically active tissue plasminogen activator

Also Published As

Publication number Publication date
FR2599625B1 (fr) 1992-03-13
DE3718939A1 (de) 1987-12-17
FI91886C (fi) 1994-08-25
HU205171B (en) 1992-03-30
ZA874054B (en) 1989-02-22
GB2191493B (en) 1991-02-27
ES2032444T3 (es) 1993-02-16
AU601984B2 (en) 1990-09-27
PT84991A (en) 1987-07-01
NO170595B (no) 1992-07-27
HUT43875A (en) 1987-12-28
GR3005245T3 (no) 1993-05-24
FI872526A (fi) 1987-12-07
EP0248675A1 (en) 1987-12-09
ATE75775T1 (de) 1992-05-15
JPS6332484A (ja) 1988-02-12
IL82746A0 (en) 1987-12-20
DK288187D0 (da) 1987-06-04
JPH0574346B2 (no) 1993-10-18
GB8713267D0 (en) 1987-07-08
PT84991B (pt) 1990-03-08
GB2191493A (en) 1987-12-16
DE3778758D1 (de) 1992-06-11
NO872395D0 (no) 1987-06-05
DK288187A (da) 1987-12-07
FR2599625A1 (fr) 1987-12-11
IE871504L (en) 1987-12-06
US5053334A (en) 1991-10-01
NZ220547A (en) 1990-01-29
NO170595C (no) 1992-11-04
AU7387287A (en) 1987-12-10
DK175366B1 (da) 2004-09-13
IE60485B1 (en) 1994-07-27
EP0248675B1 (en) 1992-05-06
FI91886B (fi) 1994-05-13
IL82746A (en) 1994-10-07
KR880000590A (ko) 1988-03-28
KR930002888B1 (ko) 1993-04-12
DE3718939C2 (de) 1998-09-17
FI872526A0 (fi) 1987-06-05
NO872395L (no) 1987-12-07

Similar Documents

Publication Publication Date Title
DE3718939C2 (de) Verfahren zur Herstellung von biologisch aktivem Plasminogenaktivator
DE3027105C2 (no)
DE69133442T2 (de) Wachstumsfördernder wirkstoff
US4533634A (en) Tissue culture medium
DE69434332T2 (de) Thrombin mutanten
DE60128861T2 (de) Methode zur Virusinaktivierung
DE69432859T2 (de) Verfahren zur reinigung von kollagenase
EP2283147A1 (de) Verfahren zur fermentativen herstellung von erythropoietin
DE69735510T2 (de) Verfahren zur Herstellung eines rekombinanten Polypeptids unter Hinzufügung eines Chymotrypsinhemmstoffes zum Zellkulturmedium
DE4118912C1 (no)
EP0971958B1 (de) Verfahren zur reinigung von faktor viii/vwf-komplex mittels kationenaustauscherchromatographie
CA1200489A (en) Method of preparation of human urine origin colony- stimulating factor and kallikrein
EP0246439B1 (de) Steriles Plasmaaustauschmittel
EP0140134A2 (de) Verfahren zur Herstellung eines biologisch aktiven Extraktes
CN107201339A (zh) 神经干细胞培养基
DE2645993A1 (de) Mittel gegen myeloische leukaemie und sein herstellungsverfahren
DE2605576C3 (de) Verfahren zum Isolieren der Proteasen Papain,,Chimopapain, Lysozym und Proteinase X aus dem Milchsaft von Carica papya und Verwendung der isolierten Proteasen zur Herstellung von sterilisierten und Iyophilisirten orthopädischen, neurochirurgischen oder ophthalmologischen Präparaten
EP0892045A2 (de) Verfahren zur Herstellung eines eine Hyaluronidase enthaltenden Präparats
EP0396597A1 (de) Verfahren zur herstellung eines therapeutisch aktiven, insbesondere zur wundheilung oder zur behandlung in der geriatrie verwendbaren wirkstoffes und ein einen solchen wirkstoff enthaltendes therapeutisches präparat
EP0910629B1 (de) Verfahren zur Herstellung einer Antidotausgangssubstanz für natürliche und synthetische Thrombininhibitoren
DD251995A5 (de) Verfahren zur Herstellung von Gewebeplasminogenaktivatoren
DD234279A5 (de) Verfahren zur herstellung einer serumunabhaengigen humanzellinie
EP0295432A2 (de) Animales Serum mit verringerter Protease- und Inhibitoraktivität
EP0238986A2 (de) Verfahren zur Herstellung eines den Blutgerinnungsfaktor VIII in ankonzentrierter Form enthaltenden Präparates

Legal Events

Date Code Title Description
IF04 In force in the year 2004

Expiry date: 20070606